Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use

NCT02977208 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Epilepsy
Chronic Pain

Interventions

PROCEDURE: Sparse blood sampling
PROCEDURE: Urine sampling
PROCEDURE: DNA extraction
DRUG: Gabapentin

Sponsor

São Paulo State University

Collaborators

[object Object]